Principles and Methodological Framework for Nucleic Acid Staining and Organelle Labeling
Principles and Methodological Framework for Nucleic Acid Staining and Organelle Labeling
Fluorescence microscopy, with its spatial resolution at the single-cell and subcellular levels, provides direct localization evidence for cellular architecture, organelle remodeling, and phenotypic responses to experimental perturbations. Compared with plate-reader assays and biochemical measurements that primarily report population-averaged signals, imaging readouts can capture both intracellular heterogeneity and morphological features, thereby improving the interpretability and resolution of phenotypic analysis. In multicolor imaging workflows, nucleic acid/nuclear stains serve as structural references for cell identification, counting, and segmentation, whereas organelle probes enable localization and dynamic visualization of structures such as lysosomes, mitochondria, the endoplasmic reticulum, lipid droplets, and the plasma membrane.
I. Nuclear/Nucleic Acid Staining
The nucleus and nucleic acids represent the most commonly used “reference signals” for structural localization, morphological observation, and quantitative analysis. Nuclear/nucleic acid staining provides stable anchors for cell counting, nuclear localization, assessment of tissue/cell distribution, and channel registration in multicolor fluorescence experiments. These stains typically generate fluorescent or chromogenic signals via binding to DNA (or nucleic acids), enabling visualization of nuclear contours, chromatin state, and nuclear morphological changes, which can support interpretation of cell-cycle status and apoptosis-associated nuclear condensation/fragmentation. Products in this category cover nuclear/nucleic acid staining systems tailored to different sample types and workflows, including Hoechst-series dyes for nuclear labeling and counterstaining, and YO-PRO-1–type reagents for nucleic acid staining following apoptosis/necrosis-associated increases in membrane permeability (to label nucleic acid signals in membrane-compromised cells). In addition, Nuclear Fast Red and crystal violet are primarily used for morphological contrast staining and brightfield observation/counting in fixed samples, and should be distinguished from fluorescence-based nuclear staining workflows in experimental design.
【Principle】
（1）Nuclear/nucleic acid staining typically relies on small-molecule dyes that interact with DNA (or RNA) through intercalation, groove binding, or electrostatic interactions, generating fluorescent or chromogenic signals under defined excitation/emission conditions to delineate nuclear contours and nucleic acid distributions.
（2）Dyes differ in membrane permeability, nucleic acid selectivity, and binding sites, and therefore can be selected to support either live-cell imaging or fixed/permeabilized samples for nuclear localization.
（3）Nuclear signals serve as baseline references for cell identification and counting; nuclear morphological features (e.g., chromatin condensation, nuclear fragmentation, abnormal nuclear boundaries) can be used to phenotype nuclear alterations associated with cellular stress or death.
（4）In multicolor fluorescence experiments, the nuclear channel is commonly used for channel registration and construction of the spatial coordinate system for image segmentation, providing structural references for organelle co-localization and quantitative imaging.
【Advantages】
（1）Nuclear localization is unambiguous and structurally relatively stable, making it well suited as a baseline signal for cell identification, counting, and multichannel registration.
（2）Broad applicability across live-cell and fixed-cell imaging, immunofluorescence counterstaining, tissue/cell coverslip preparations, and high-content imaging analyses.
（3）Provides fundamental support for quantitative workflows, including intensity normalization on a per-cell/per-nucleus basis, cell-density control, and phenotypic statistics.
（4）Useful for workflow QC, enabling assessment of fixation/permeabilization performance, background levels, and sample integrity, thereby improving comparability of imaging datasets.
【Limitations and Notes】
（1）Membrane permeability and cytotoxicity vary substantially across nucleic acid dyes; for long-term live-cell imaging, phototoxicity and potential perturbations to processes such as cell-cycle progression and transcription should be evaluated.
（2）Some dyes exhibit partial affinity for RNA or sensitivity to chromatin state, which may increase intranuclear heterogeneity and background; when strict DNA specificity is required, RNase treatment can be considered to reduce RNA-derived background.
（3）Fixation/permeabilization conditions can alter chromatin compaction and nuclear structure, affecting staining intensity and morphological parameters; cross-batch comparisons require consistent processing and imaging settings.
（4）Multicolor imaging requires control of spectral bleed-through—particularly when the blue/violet excitation channel is adjacent to other commonly used channels—by appropriate filter sets, exposure strategies, and single-channel controls to stabilize thresholding.
【Aladdin-related Products】
Catalog No. | Product Name | CAS No. | Grade and Purity | Applications |
Hoechst 33258 Staining Solution | 23491-45-4 | BioReagent, Biological Stain, Biological dye grade, Suitable for Immunofluorescence(IF), for fluorescence analysis, for cell culture, for microscopy, ready-to-use, 1.0 mg/mL in H₂O | Nuclear DNA staining and nuclei counting; nuclear morphology observation in fixed/permeabilized samples; immunofluorescence counterstaining (nuclear control); characterization of apoptosis-/cell cycle–associated nuclear condensation and fragmentation | |
Hoechst 33342 Staining Solution | 23491-52-3 | Suitable for Immunofluorescence(IF), BioReagent, ready-to-use, Biological Stain, for fluorescence analysis, Biological dye grade, for microscopy, for cell culture, 1.0 mg/ml in H₂O | Nuclear staining and nuclei counting in live or fixed cells; nuclear localization and nuclear morphology observation; multicolor immunofluorescence counterstaining; nuclear labeling for cell-cycle analysis or live-cell imaging | |
YO-PRO-1 3D Staining Solution | — | BioReagent, for microscopy, ready-to-use, Biological Stain | Nucleic-acid fluorescent staining of apoptotic or membrane-compromised cells in 3D cultures, organoids, or tissue samples (to label nucleic-acid signals associated with altered membrane permeability); used for microscopy-based visualization of the spatial distribution and morphology of death-associated cells in 3D specimens | |
YO-PRO-1/RNase Nuclear Staining Solution | — | BioReagent, ready-to-use, Biological Stain, for microscopy | Nuclear DNA staining (with RNase to reduce RNA background); nuclei counting and nuclear morphology observation; sample preparation prior to cell-cycle/nucleic-acid quantitative imaging (improved signal-to-noise) | |
Nuclear Fast Red | 6409-77-4 | Biological Stain | Nuclear counterstaining for tissues/cytology; nuclear morphology observation and histology/cytology background staining; structural reference used in combination with other staining systems | |
Nuclear Fast Red Staining Solution | 6409-77-4 | BioReagent, Biological Stain, for microscopy, 0.1% | Nuclear counterstaining for tissues or cells; microscopic observation of nuclear structure and localization; combined with cytoplasmic/matrix stains for morphological assessment | |
Crystal Violet–Citrate Staining Solution | — | BioReagent, Biological Stain, for microscopy, 0.1% | Cell staining and morphological observation; visualization and semi-quantification for adherent-cell staining after fixation (cell counting/colony formation assays); routine staining and contrast enhancement for bacterial/cell smears | |
Green Nuclear Probe (Aggregation-Induced Emission, AIE) |
| BioReagent, for microscopy, Biological Stain, ≥98%(HPLC), 50mM | Green fluorescent nuclear labeling and nuclei counting; nuclear localization imaging in live cells or fixed samples; green nuclear control for multicolor immunofluorescence/live-cell imaging and long-term observation (AIE feature improves imaging stability) |
II. Fluorescent Probes and Labeling
Spatial localization of organelles and subcellular structures—and their dynamic remodeling—provides foundational information for interpreting cellular functional states and stress responses. This class of fluorescent probes enables rapid labeling of lysosomes, mitochondria, endoplasmic reticulum, lipid droplets, the plasma membrane, and bacteria through selective accumulation or preferential binding, facilitating morphological observation, co-localization analysis, and quantitative imaging on fluorescence microscopy or fluorescence analysis platforms. The product portfolio includes AIE (aggregation-induced emission) probes, tracker-type organelle probes, and indicators (e.g., Calcein-AM), supporting multicolor panel design and live-cell imaging workflows to enable intuitive assessment of organelle distribution, number/morphology changes, and associated functional states.
【Principle】
（1）Organelle fluorescent probes typically label subcellular structures via physicochemical property–driven selective accumulation (e.g., enrichment in acidic compartments, membrane potential dependence, hydrophobic partitioning) and/or structure–receptor interactions, enabling marking of lysosomes, mitochondria, the endoplasmic reticulum, lipid droplets, and the plasma membrane.
（2）Probe signals reflect not only spatial localization but may also be influenced by the local microenvironment (pH, membrane potential, viscosity, ionic milieu, etc.); therefore, signal changes from the same probe can include contributions from both “distribution/morphology changes” and “functional state changes.”
（3）Organelle-probe imaging enables extraction of phenotypic parameters such as organelle number, area, morphology, and network architecture, and can be combined with nuclear stains or other structural markers for co-localization and subcellular region segmentation.
（4）In multicolor experimental panels, organelle probes can be combined with immunofluorescence, nuclear staining, and membrane labeling to enable parallel readouts of organelle distribution and cell-state metrics, supporting mechanistic studies and phenotypic screening.
【Advantages】
（1）Provides subcellular-scale spatial information, linking molecular changes to organelle remodeling, intracellular trafficking, and stress responses, thereby strengthening spatial evidence for mechanistic interpretation.
（2）Compatible with live-cell imaging and dynamic observation, enabling investigation of organelle dynamics and time-resolved phenotypic remodeling induced by experimental perturbations.
（3）Facilitates multicolor co-localization and high-content screening, delivering intuitive and quantifiable readouts in pharmacological evaluation, autophagy–lysosome pathway studies, mitochondrial dynamics research, and lipid-metabolism phenotyping.
（4）Offers diverse probe systems and channel options that can be flexibly combined according to instrument excitation configurations and multicolor panel requirements.
【Limitations and Notes】
（1）Most small-molecule probes exhibit “selective accumulation” rather than strict single-target specificity; co-localization validation and process controls are recommended to confirm structural attribution of signals.
（2）Live-cell imaging entails risks of photobleaching and phototoxicity; optimize probe concentration, exposure time, frame rate, and excitation power to avoid imaging-induced organelle phenotypes.
（3）Changes in organelle state (e.g., acidification level or membrane potential) can alter probe accumulation and fluorescence quantum yield, making signal changes non-equivalent to “organelle abundance changes.” Use appropriate controls to disentangle contributions from “localization changes” versus “environmental changes.”
（4）Multicolor panels require management of spectral bleed-through and workflow compatibility. Some probes are optimized for immediate live-cell imaging and may be incompatible with subsequent fixation/permeabilization or immunofluorescence steps; these constraints should be explicitly addressed during protocol design.
【Aladdin-related Products】
Catalog No. | Product Name | Grade and Purity | Applications |
Lyso-Tracker Green (Lysosome Green Fluorescent Probe) | Suitable for Immunofluorescence(IF), BioReagent, Biological Stain, Suitable for molecular biology, 1mM | Live-cell lysosome labeling and localization imaging; observation of lysosome number/morphology changes; studies of the autophagy–lysosome pathway and lysosome function (fluorescence microscopy/fluorescence analysis) | |
Endoplasmic Reticulum Yellow Probe (Aggregation-Induced Emission, AIE) | BioReagent, for microscopy, Biological Stain, 10mM in DMSO | Endoplasmic reticulum (ER) localization staining and imaging; observation of ER morphology and distribution; organelle labeling for studies of ER stress and protein folding/secretion pathways | |
Lysosome Red Probe (Aggregation-Induced Emission, AIE) | BioReagent, for microscopy, Biological Stain, ≥98%(HPLC), 10mM in DMSO | Live-cell red lysosome imaging; multicolor co-localization with other organelle probes; studies of lysosomal functional changes (acidification, aggregation, morphology) | |
Mitochondria Red Probe (Aggregation-Induced Emission, AIE) | BioReagent, for microscopy, Biological Stain, ≥98%(HPLC), 50mM in DMSO | Mitochondrial localization imaging and network morphology observation; studies of mitochondrial dynamics (fusion/fission); evaluation of mitochondrial phenotypes in cellular metabolism, oxidative stress, and apoptosis | |
Cell Membrane Red Probe (Aggregation-Induced Emission, AIE) | BioReagent, for microscopy, Biological Stain, ≥98%(HPLC), 10mM in DMSO | Plasma membrane labeling and outline delineation; observation of cell morphology, membrane architecture, and membrane dynamics; co-localization with organelle/nuclear stains for boundary segmentation analyses | |
Cell Membrane Green Probe (Aggregation-Induced Emission, AIE) | BioReagent, for microscopy, Biological Stain, ≥98%(HPLC), 10mM in DMSO | Green plasma membrane imaging; cell-boundary identification and morphometric analysis; combination with red/blue-channel probes for multicolor co-localization and segmentation workflows | |
Bacteria Red Probe (Aggregation-Induced Emission, AIE) | BioReagent, for microscopy, Biological Stain, ≥98%(HPLC), 10mM in DMSO | Rapid fluorescent labeling and imaging of bacteria; observation of bacterial adhesion/invasion or host–pathogen interactions; assessment of bacterial distribution and burden changes before/after antimicrobial treatment | |
Lipid Droplet Red Probe (Aggregation-Induced Emission, AIE) | BioReagent, for microscopy, Biological Stain, ≥98%(HPLC), 200μM | Specific intracellular lipid droplet labeling and imaging; monitoring dynamics of lipid metabolism and lipid droplet biogenesis/consumption; evaluation of steatosis and metabolic-stress models | |
Lipid Droplet Blue Probe (Aggregation-Induced Emission, AIE) | BioReagent, for microscopy, Biological Stain, ≥98%(HPLC), 1mM | Blue-channel lipid droplet imaging; compatible with commonly used green/red-channel assays for multicolor co-localization; quantitative analysis of lipid metabolism and lipid droplet phenotypes | |
Lipid Droplet Yellow Probe (Aggregation-Induced Emission, AIE) | BioReagent, for microscopy, Biological Stain, ≥98%(HPLC), 10mM in DMSO | Lipid droplet localization staining and imaging (yellow channel); additional channel option for multicolor panel design; assessment of lipid droplet morphology, number, and distribution changes | |
Calcein-AM Solution | BioReagent, for microscopy, Biological Stain, Suitable for Immunofluorescence(IF), for fluorescence analysis, for cell culture, sterile-filtered, 2 mM in DMSO | Live-cell fluorescent labeling and viability assessment (Calcein-AM live/dead staining: intracellular esterases convert to green fluorescence in viable cells); viability imaging for cell adhesion/migration and 3D culture; combined with PI/7-AAD to distinguish live/dead cells and assess cytotoxicity |
Nuclear/nucleic acid staining provides a stable structural reference and quantitative baseline for imaging experiments, whereas organelle fluorescent probes deliver subcellular localization information and morphology-based phenotypic readouts. When used in combination, these two modules enable a systematic workflow spanning “cell identification and normalization” through to integrated analyses of organelle distribution, co-localization, and remodeling phenotypes. To obtain reproducible and interpretable results, experimental design should prioritize comprehensive channel planning and control configuration, together with stringent standardization of sample-processing workflows and imaging parameters, thereby minimizing systematic signal distortion arising from spectral bleed-through, procedural variability, and microenvironmental effects.
Aladdin: https://www.aladdinsci.com/